Literature DB >> 23149014

Zinc finger function of HIV-1 nucleocapsid protein is required for removal of 5'-terminal genomic RNA fragments: a paradigm for RNA removal reactions in HIV-1 reverse transcription.

Christopher B Hergott1, Mithun Mitra, Jianhui Guo, Tiyun Wu, Jennifer T Miller, Yasumasa Iwatani, Robert J Gorelick, Judith G Levin.   

Abstract

During (-) strong-stop DNA [(-) SSDNA] synthesis, RNase H cleavage of genomic viral RNA generates small 5'-terminal RNA fragments (14-18 nt) that remain annealed to the DNA. Unless these fragments are removed, the minus-strand transfer reaction, required for (-) SSDNA elongation, cannot occur. Here, we describe the mechanism of 5'-terminal RNA removal and the roles of HIV-1 nucleocapsid protein (NC) and RNase H cleavage in this process. Using an NC-dependent system that models minus-strand transfer, we show that the presence of short terminal fragments pre-annealed to (-) SSDNA has no impact on strand transfer, implying efficient fragment removal. Moreover, in reactions with an RNase H(-) reverse transcriptase mutant, NC alone is able to facilitate fragment removal, albeit less efficiently than in the presence of both RNase H activity and NC. Results obtained from novel electrophoretic gel mobility shift and Förster Resonance Energy Transfer assays, which each directly measure RNA fragment release from a duplex in the absence of DNA synthesis, demonstrate for the first time that the architectural integrity of NC's zinc finger (ZF) domains is absolutely required for this reaction. This suggests that NC's helix destabilizing activity (associated with the ZFs) facilitates strand exchange through the displacement of these short terminal RNAs by the longer 3' acceptor RNA, which forms a more stable duplex with (-) SSDNA. Taken together with previously published results, we conclude that NC-mediated fragment removal is linked mechanistically with selection of the correct primer for plus-strand DNA synthesis and tRNA removal step prior to plus-strand transfer. Thus, HIV-1 has evolved a single mechanism for these RNA removal reactions that are critical for successful reverse transcription. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23149014      PMCID: PMC3578084          DOI: 10.1016/j.virusres.2012.08.013

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  57 in total

1.  Characterization of the inhibition mechanism of HIV-1 nucleocapsid protein chaperone activities by methylated oligoribonucleotides.

Authors:  Sergiy V Avilov; Christian Boudier; Marina Gottikh; Jean-Luc Darlix; Yves Mély
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

Review 2.  Biophysical studies of the nucleic acid chaperone properties of the HIV-1 nucleocapsid protein.

Authors:  Julien Godet; Yves Mély
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

Review 3.  Role of HIV-1 nucleocapsid protein in HIV-1 reverse transcription.

Authors:  Judith G Levin; Mithun Mitra; Anjali Mascarenhas; Karin Musier-Forsyth
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

Review 4.  Requirements for efficient minus strand strong-stop DNA transfer in human immunodeficiency virus 1.

Authors:  Dorota Piekna-Przybylska; Robert A Bambara
Journal:  RNA Biol       Date:  2011-03-01       Impact factor: 4.652

Review 5.  Flexible nature and specific functions of the HIV-1 nucleocapsid protein.

Authors:  Jean-Luc Darlix; Julien Godet; Roland Ivanyi-Nagy; Philippe Fossé; Olivier Mauffret; Yves Mély
Journal:  J Mol Biol       Date:  2011-07-22       Impact factor: 5.469

6.  Fundamental differences between the nucleic acid chaperone activities of HIV-1 nucleocapsid protein and Gag or Gag-derived proteins: biological implications.

Authors:  Tiyun Wu; Siddhartha A K Datta; Mithun Mitra; Robert J Gorelick; Alan Rein; Judith G Levin
Journal:  Virology       Date:  2010-07-23       Impact factor: 3.616

7.  Inhibition of HIV-1 replication by a bis-thiadiazolbenzene-1,2-diamine that chelates zinc ions from retroviral nucleocapsid zinc fingers.

Authors:  Christophe Pannecouque; Beata Szafarowicz; Natalia Volkova; Vasiliy Bakulev; Wim Dehaen; Yves Mély; Dirk Daelemans
Journal:  Antimicrob Agents Chemother       Date:  2010-02-01       Impact factor: 5.191

Review 8.  Maturation of the HIV reverse transcription complex: putting the jigsaw together.

Authors:  David Warrilow; Gilda Tachedjian; David Harrich
Journal:  Rev Med Virol       Date:  2009-11       Impact factor: 6.989

9.  Identification of HIV-1 inhibitors targeting the nucleocapsid protein.

Authors:  Sebastian Breuer; Max W Chang; Jinyun Yuan; Bruce E Torbett
Journal:  J Med Chem       Date:  2012-05-24       Impact factor: 7.446

10.  Identification of a methylated oligoribonucleotide as a potent inhibitor of HIV-1 reverse transcription complex.

Authors:  Boyan Grigorov; Anne Bocquin; Caroline Gabus; Sergey Avilov; Yves Mély; Audrey Agopian; Gilles Divita; Marina Gottikh; Myriam Witvrouw; Jean-Luc Darlix
Journal:  Nucleic Acids Res       Date:  2011-03-29       Impact factor: 16.971

View more
  8 in total

1.  Selection of fully processed HIV-1 nucleocapsid protein is required for optimal nucleic acid chaperone activity in reverse transcription.

Authors:  Tiyun Wu; Robert J Gorelick; Judith G Levin
Journal:  Virus Res       Date:  2014-06-20       Impact factor: 3.303

2.  A protein ballet around the viral genome orchestrated by HIV-1 reverse transcriptase leads to an architectural switch: from nucleocapsid-condensed RNA to Vpr-bridged DNA.

Authors:  Sébastien Lyonnais; Robert J Gorelick; Fatima Heniche-Boukhalfa; Serge Bouaziz; Vincent Parissi; Jean-François Mouscadet; Tobias Restle; Jose Maria Gatell; Eric Le Cam; Gilles Mirambeau
Journal:  Virus Res       Date:  2012-09-24       Impact factor: 3.303

3.  The N-terminal zinc finger and flanking basic domains represent the minimal region of the human immunodeficiency virus type-1 nucleocapsid protein for targeting chaperone function.

Authors:  Mithun Mitra; Wei Wang; My-Nuong Vo; Ioulia Rouzina; George Barany; Karin Musier-Forsyth
Journal:  Biochemistry       Date:  2013-11-06       Impact factor: 3.162

4.  Insights into the mechanisms of RNA secondary structure destabilization by the HIV-1 nucleocapsid protein.

Authors:  Anissa Belfetmi; Loussiné Zargarian; Carine Tisné; Dona Sleiman; Nelly Morellet; Ewen Lescop; Ouerdia Maskri; Brigitte René; Yves Mély; Philippe Fossé; Olivier Mauffret
Journal:  RNA       Date:  2016-01-29       Impact factor: 4.942

5.  Mechanistic differences between HIV-1 and SIV nucleocapsid proteins and cross-species HIV-1 genomic RNA recognition.

Authors:  Klara Post; Erik D Olson; M Nabuan Naufer; Robert J Gorelick; Ioulia Rouzina; Mark C Williams; Karin Musier-Forsyth; Judith G Levin
Journal:  Retrovirology       Date:  2016-12-29       Impact factor: 4.602

Review 6.  Nucleocapsid Protein: A Desirable Target for Future Therapies Against HIV-1.

Authors:  Mattia Mori; Lesia Kovalenko; Sébastien Lyonnais; Danny Antaki; Bruce E Torbett; Maurizio Botta; Gilles Mirambeau; Yves Mély
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

7.  Differential contribution of basic residues to HIV-1 nucleocapsid protein's nucleic acid chaperone function and retroviral replication.

Authors:  Hao Wu; Mithun Mitra; M Nabuan Naufer; Micah J McCauley; Robert J Gorelick; Ioulia Rouzina; Karin Musier-Forsyth; Mark C Williams
Journal:  Nucleic Acids Res       Date:  2013-11-28       Impact factor: 16.971

Review 8.  Retroviral nucleocapsid proteins and DNA strand transfers.

Authors:  Brigitte René; Olivier Mauffret; Philippe Fossé
Journal:  Biochim Open       Date:  2018-07-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.